Oncology Central

Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume


Aim: To assess hematologic changes of modern prostate radiation therapy (RT) comparing different target volumes. Patients & methods: Blood samples were evaluated before (T1), during (T2–T4) and 6–8 weeks after (T5) RT in a group of 113 patients. Whole-pelvic RT up to 46 Gy was applied in 27 cases. The total dose to the prostatic fossa (n = 46)/prostate (n = 67) was 66/76 Gy.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.